{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:30:36Z","timestamp":1777879836692,"version":"3.51.4"},"reference-count":62,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T00:00:00Z","timestamp":1539129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Workplace Health Saf"],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:p>The opioid epidemic is a national public health crisis. It began with the misuse of commonly used prescription opioid pain relievers and has led to the increased use of heroin and illicit fentanyl. Large-scale initiatives have begun on the federal and state level and place an emphasis on improved opioid prescribing, which have important implications for the workplace. Treatment of work injury may initiate the use of prescription opioids and result in misuse and possible overdose. Prescription drug abuse affects all aspects of society so potentially any workplace could be affected. A multifaceted approach is needed to reduce opioid morbidity and mortality and the occupational health nurse should be actively involved. The intent of this article is to provide an overview of the epidemic and its impact on health, the challenges for the workplace, and recommended strategies for the occupational health nurse to impact the problem.<\/jats:p>","DOI":"10.1177\/2165079918796242","type":"journal-article","created":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T02:59:33Z","timestamp":1539226773000},"page":"36-45","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":6,"title":["The Opioid Epidemic and the Role of the Occupational Health Nurse"],"prefix":"10.1177","volume":"67","author":[{"given":"Sheila A.","family":"Higgins","sequence":"first","affiliation":[{"name":"NC Division of Public Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Simons","sequence":"additional","affiliation":[{"name":"Procter &amp; Gamble"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2018,10,10]]},"reference":[{"key":"e_1_3_3_2_1","unstructured":"American Association of Occupational Health Nurses. (2018). Position statement. The occupational health nurse\u2019s (OHNs) role in addressing the opioid crisis in the workplace. Retrieved from http:\/\/aaohn.org\/page\/position-statements"},{"key":"e_1_3_3_3_1","unstructured":"The American Medical Chest Challenge. (2010). Drop off locations. Available from http:\/\/www.americanmedicinechest.com"},{"key":"e_1_3_3_4_1","unstructured":"Athenahealth. (2017). Infographic: State-by-state breakdown of opioid regulations. AthenaInsight. Retrieved from https:\/\/www.athenahealth.com\/insight\/infographic-opioid-regulations-state-by-state"},{"key":"e_1_3_3_5_1","unstructured":"Centers for Disease Control and Prevention. (2015). Today\u2019s heroin epidemic. Retrieved from https:\/\/www.cdc.gov\/vitalsigns\/heroin\/index.html"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6501e1"},{"key":"e_1_3_3_7_1","unstructured":"Centers for Disease Control and Prevention. (2017a). Fentanyl. Retrieved from https:\/\/www.cdc.gov\/drugoverdose\/opioids\/fentanyl.html"},{"key":"e_1_3_3_8_1","unstructured":"Centers for Disease Control and Prevention. (2017b). Guideline for prescribing opioids for chronic pain [Factsheet]. Retrieved from https:\/\/www.cdc.gov\/drugoverdose\/pdf\/guidelines_factsheet-a.pdf"},{"key":"e_1_3_3_9_1","unstructured":"Centers for Disease Control and Prevention. (2017c). Opioid data analysis. Categories of opioids. Retrieved from https:\/\/www.cdc.gov\/drugoverdose\/data\/analysis.html"},{"key":"e_1_3_3_10_1","unstructured":"Centers for Disease Control and Prevention. (2017d). Overdose prevention. Retrieved from https:\/\/www.cdc.gov\/drugoverdose\/prevention\/index.html"},{"key":"e_1_3_3_11_1","unstructured":"Centers for Disease Control and Prevention. (2017e). Prescription drug monitoring programs (PDMPs) [Factsheet]. Retrieved from https:\/\/www.cdc.gov\/drugoverdose\/pdf\/PDMP_Factsheet-a.pdf"},{"key":"e_1_3_3_12_1","unstructured":"Centers for Disease Control and Prevention. (2017f). Prescription opioids. Retrieved from https:\/\/www.cdc.gov\/drugoverdose\/opioids\/prescribed.html"},{"key":"e_1_3_3_13_1","unstructured":"Centers for Disease Control and Prevention. (2017g). Promising state strategies. Retrieved from https:\/\/www.cdc.gov\/drugoverdose\/policy\/index.html"},{"key":"e_1_3_3_14_1","unstructured":"Centers for Disease Control and Prevention\/National Center for Health Statistics. (2017). National vital statistical system morality (CDC WONDER). Atlanta GA: U.S. Department of Health and Human Services Centers for Disease Control and Prevention. Available from https:\/\/wonder.cdc.gov\/"},{"key":"e_1_3_3_15_1","unstructured":"Centers for Disease Control and Prevention National Center for Injury Prevention and Control. (2017). Annual surveillance report of drug related risks and outcomes\u2014United States 2017 (Surveillance Source Report No. 1). Retrieved from https:\/\/www.cdc.gov\/drugoverdose\/pdf\/pubs\/2017-cdc-drug-surveillance-report.pdf"},{"key":"e_1_3_3_16_1","unstructured":"Christie C. Baker C. Cooper R. Kennedy P. J. Madras B. Bondi P. (2017). The president\u2019s commission on combating drug addiction and the opioid crisis. Retrieved from https:\/\/www.whitehouse.gov\/sites\/whitehouse.gov\/files\/images\/Final_Report_Draft_11-1-2017.pdf"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2018.05.030"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6634a3"},{"issue":"1","key":"e_1_3_3_19_1","first-page":"1","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"65","author":"Dowell D.","year":"2016","unstructured":"Dowell D., Haegerich T., Chou R. (2016). CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016. Morbidity and Mortality Weekly Report, 65(1), 1-49.","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.3928\/216507799-20121128-74"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/BRS.0b013e318198d504"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwn364"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/JOM.0000000000001157"},{"key":"e_1_3_3_24_1","unstructured":"Government Publishing Office. (2017). Procedures for transportation workplace drug and alcohol testing programs: Addition of certain schedule II drugs to the Department of Transportation\u2019s drug-testing panel and certain minor amendments (Federal Register\/Vol. 82 No. 217\/Monday November 13 2017\/Rules and Regulations. Department of Transportation 49 CFR Part 40). Retrieved from https:\/\/www.gpo.gov\/fdsys\/pkg\/FR-2017-11-13\/pdf\/2017-24397.pdf"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.7326\/M17-0865"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/JOM.0000000000000237"},{"key":"e_1_3_3_27_1","unstructured":"Jaffe D. (2016). What is the PDMP and does my state have it? IWP the patient advocate pharmacy. Retrieved from http:\/\/info.iwpharmacy.com\/what-is-the-pdmp"},{"issue":"26","key":"e_1_3_3_28_1","first-page":"569","article-title":"Decline in overdose deaths after state policy changes\u2014Florida, 2010-2012","volume":"63","author":"Johnson H.","year":"2014","unstructured":"Johnson H., Paulozzi L., Porucznik C., Mack K., Herter B. (2014). Decline in overdose deaths after state policy changes\u2014Florida, 2010-2012. Morbidity and Mortality Weekly Report, 63(26), 569-574.","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-publhealth-031914-122957"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2015.02.020"},{"key":"e_1_3_3_31_1","unstructured":"Muhuri P. K. Gfroerer J. C. Davies M. C. (2013 August). Associations of nonmedical pain reliever use and initiation of heroin use in the United States. SAMHSA CBHSQ Data Review. Retrieved from https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/DR006\/DR006\/nonmedical-pain-reliever-use-2013.htm"},{"key":"e_1_3_3_32_1","unstructured":"National Council on Compensation Insurance. (2016). NCCI research brief: Workers compensation prescription drug study: 2016 update. Retrieved from https:\/\/www.ncci.com\/Articles\/Documents\/II_ResearchBrief_WC_Prescription_Drugs.pdf"},{"key":"e_1_3_3_33_1","unstructured":"National Institute of Occupational Safety and Health\/Centers for Disease Control and Prevention. (2017). Prescription drug overdose prevention. Retrieved from https:\/\/www.cdc.gov\/niosh\/topics\/prescription\/default.htmll"},{"key":"e_1_3_3_34_1","unstructured":"National Institute on Drug Abuse. (2016). Understanding drug use and addiction. Retrieved from https:\/\/www.drugabuse.gov\/publications\/drugfacts\/understanding-drug-use-addiction"},{"key":"e_1_3_3_35_1","unstructured":"National Institute on Drug Abuse. (2017a). Brief description. Retrieved from https:\/\/www.drugabuse.gov\/drugs-abuse\/opioids"},{"key":"e_1_3_3_36_1","unstructured":"National Institute on Drug Abuse. (2017b). Heroin. Retrieved from https:\/\/www.drugabuse.gov\/publications\/drugfacts\/heroin"},{"key":"e_1_3_3_37_1","unstructured":"National Institute on Drug Abuse. (2017c). Medications to treat opioid addiction. Retrieved from https:\/\/www.drugabuse.gov\/publications\/effective-treatments-opioid-addiction\/effective-treatments-opioid-addiction"},{"key":"e_1_3_3_38_1","unstructured":"National Institute on Drug Abuse. (2017d). Misuse of prescription drugs. Retrieved from https:\/\/www.drugabuse.gov\/publications\/research-reports\/misuse-prescription-drugs\/what-scope-prescription-drug-misuse"},{"key":"e_1_3_3_39_1","unstructured":"National Institute on Drug Abuse. (2018). Opioid overdose crisis. Retrieved from https:\/\/www.drugabuse.gov\/drugs-abuse\/opioids\/opioid-crisis"},{"key":"e_1_3_3_40_1","unstructured":"National Safety Council. (2015). The proactive role employers can take: Opioids in the workplace. Retrieved from https:\/\/www.nsc.org\/Portals\/0\/Documents\/RxDrugOverdoseDocuments\/RxKit\/The-Proactive-Role-Employers-Can-Take-Opioids-in-the-Workplace.pdf"},{"key":"e_1_3_3_41_1","unstructured":"North Carolina Medical Society. (2018). Opioid prescribing rules for workers compensation. Retrieved from http:\/\/www.ncmedsoc.org\/wp-content\/uploads\/2018\/05\/ncic-opioid-prescribing-rules-summary.pdf"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6634a2"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6643e1"},{"key":"e_1_3_3_44_1","unstructured":"Office of the Surgeon General U.S. Department of Health and Human Services. (2016). Facing addiction in America: The surgeon general\u2019s report on alcohol drugs and health. Retrieved from https:\/\/www.surgeongeneral.gov\/library\/2016alcoholdrugshealth\/index.html"},{"key":"e_1_3_3_45_1","first-page":"1487","article-title":"Vital signs: Overdoses of prescription opioid pain relievers\u2014United States, 1999-2008","volume":"60","author":"Paulozzi L. J.","year":"2011","unstructured":"Paulozzi L. J., Jones C. M., Mack K. A., Rudd R. A. (2011). Vital signs: Overdoses of prescription opioid pain relievers\u2014United States, 1999-2008. Morbidity and Mortality Weekly Report, 60, 1487-1492.","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1177\/2165079917733753"},{"key":"e_1_3_3_47_1","volume-title":"Occupational health nursing: Concepts and practice","author":"Rogers B.","year":"1994","unstructured":"Rogers B. (1994). Occupational health nursing: Concepts and practice. Philadelphia, PA: W.B. Saunders."},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6450a3"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm655051e1"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14905"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6610a1"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2006.05.008"},{"key":"e_1_3_3_53_1","unstructured":"Substance Abuse and Mental Health Services Administration. (2015). Drug free workplace programs: Federal contractors and grantees. Retrieved from https:\/\/www.samhsa.gov\/workplace\/legal\/federal-laws\/contractors-grantees"},{"key":"e_1_3_3_54_1","unstructured":"Substance Abuse and Mental Health Services Administration. (2017a). Modifying drug-free workplace programs to address nonmedical use of prescription drugs [Factsheet]. Retrieved from http:\/\/publichealth.hsc.wvu.edu\/media\/4168\/drug_free_workplace_3_web_-508.pdf"},{"key":"e_1_3_3_55_1","unstructured":"Substance Abuse and Mental Health Services Administration. (2017b). Prescription drug awareness: Information for employers [Factsheet]. Retrieved from http:\/\/publichealth.hsc.wvu.edu\/media\/3324\/paw_business_final_email_no-samhsa-logo.pdf"},{"key":"e_1_3_3_56_1","unstructured":"U.S. Department of Justice Drug Enforcement Administration. (2015). DEA issues nationwide alert on fentanyl as threat to health and public safety. Retrieved from https:\/\/www.dea.gov\/divisions\/hq\/2015\/hq031815.shtml"},{"key":"e_1_3_3_57_1","unstructured":"U.S. Department of Justice Drug Enforcement Administration. (2016). National drug threat assessment summary. Retrieved from https:\/\/search.dea.gov\/search?query=2016+national+drug+threat+assesment+summary&affiliate=justice-dea"},{"key":"e_1_3_3_58_1","unstructured":"U.S. Department of Labor Bureau of Labor Statistics. (2017 December). News release: National census of fatal occupational injuries in 2016 (USDL-17-1667). Retrieved from https:\/\/www.bls.gov\/news.release\/pdf\/cfoi.pdf"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1097\/BRS.0b013e318145a731"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1176\/ps.2009.60.5.646"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1097\/JOM.0b013e318252249b"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1475-6773.2004.00217.x"},{"key":"e_1_3_3_63_1","first-page":"13","article-title":"Reducing the impact of opioids in North Carolina","author":"Woods L.","year":"2018","unstructured":"Woods L. (2018, Winter). Reducing the impact of opioids in North Carolina. Tar Heel Nurse, Official Publication of the North Carolina Nurses Association, p. 13.","journal-title":"Tar Heel Nurse, Official Publication of the North Carolina Nurses Association"}],"container-title":["Workplace Health &amp; Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2165079918796242","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2165079918796242","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2165079918796242","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:55:09Z","timestamp":1777593309000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/2165079918796242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,10]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["10.1177\/2165079918796242"],"URL":"https:\/\/doi.org\/10.1177\/2165079918796242","relation":{},"ISSN":["2165-0799","2165-0969"],"issn-type":[{"value":"2165-0799","type":"print"},{"value":"2165-0969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,10]]}}}